{"filing":{"accession_number":"0001213900-26-103604","cik":"0001839285","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","form":"8-K","filing_date":"2026-09-25","report_date":"2026-09-22","primary_document":"ea0306547-8k_healthcare.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026103604/ea0306547-8k_healthcare.htm"},"events":[{"id":35208,"run_id":32418,"accession_number":"0001213900-26-103604","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Healthcare Triangle entered into a First Amendment to an Equity Purchase Agreement with Hudson Global Ventures on September 22, 2026, modifying key terms of a June 2026 equity arrangement. The Amendment restructures the put-right mechanics (reducing maximum put amount from $2.5M to $250K per notice, raising minimum price per share from $0.01 to $0.10) and adds a Change of Control provision. While the filing does not explicitly state the total equity issuance amount or fully disclose the original agreement's structure, the amendment to an equity purchase agreement involving a private investor constitutes a material modification to a dilutive capital arrangement. The reduction in maximum put amount and increase in minimum price suggest negotiated adjustments to an existing equity commitment, consistent with dilutive issuance disclosure obligations under Item 3.02 or Item 1.01 for material definitive agreements.","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-09-25","form":"8-K","submitted_at":null,"items":[{"id":39174,"accession_number":"0001213900-26-103604","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Healthcare Triangle entered into a First Amendment to an Equity Purchase Agreement with Hudson Global Ventures on September 22, 2026, modifying key terms of a June 2026 equity arrangement. The Amendment restructures the put-right mechanics (reducing maximum put amount from $2.5M to $250K per notice, raising minimum price per share from $0.01 to $0.10) and adds a Change of Control provision. While the filing does not explicitly state the total equity issuance amount or fully disclose the original agreement's structure, the amendment to an equity purchase agreement involving a private investor constitutes a material modification to a dilutive capital arrangement. The reduction in maximum put amount and increase in minimum price suggest negotiated adjustments to an existing equity commitment, consistent with dilutive issuance disclosure obligations under Item 3.02 or Item 1.01 for material definitive agreements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:27:07.547850+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39174,"accession_number":"0001213900-26-103604","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Healthcare Triangle entered into a First Amendment to an Equity Purchase Agreement with Hudson Global Ventures on September 22, 2026, modifying key terms of a June 2026 equity arrangement. The Amendment restructures the put-right mechanics (reducing maximum put amount from $2.5M to $250K per notice, raising minimum price per share from $0.01 to $0.10) and adds a Change of Control provision. While the filing does not explicitly state the total equity issuance amount or fully disclose the original agreement's structure, the amendment to an equity purchase agreement involving a private investor constitutes a material modification to a dilutive capital arrangement. The reduction in maximum put amount and increase in minimum price suggest negotiated adjustments to an existing equity commitment, consistent with dilutive issuance disclosure obligations under Item 3.02 or Item 1.01 for material definitive agreements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T21:27:07.547850+00:00","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-09-25"}]}